MedPath

Lidocaine-prilocaine Cream Versus Rectal Meloxicam on Relief of Post-episiotomy Pain

Phase 3
Completed
Conditions
Postpartum
Interventions
Drug: lidocaine-prilocaine cream
Registration Number
NCT03146000
Lead Sponsor
Assiut University
Brief Summary

Postpartum perineal pain is a very common complaint. It can have negative consequences for mother and child including disability in daily functioning for the mother; for example, it can interfere in taking care of her infant and in breastfeeding. Early pain management is thus relevant to provide relief and prevent chronicity.

Perineal pain is particularly common following childbirth. Macarthur 2004, in a prospective cohort study involving 447 women in Canada, reported an incidence of perineal pain, in the first day after birth, of 75% in women with an intact perineum

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
Female
Target Recruitment
190
Inclusion Criteria
  1. Primiparas
  2. Normal vaginal delivery
  3. Mediolateral episiotomy
  4. Ability to understand and the willingness to sign a written informed consent
Exclusion Criteria
  1. Patients who had postpartum hemorrhage
  2. Patients who had manual removal of the placenta
  3. Patients with contraindications to non steroidal drugs
  4. Patients with a multiple perineal lacerations

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
meloxicammeloxicam rectal suppositorywomen will receive one 15 mg meloxicam rectal suppository
lidocaine-prilocainelidocaine-prilocaine creamwomen will receive 5 mg lidocaine-prilocaine cream topically on the episiotomy line
Primary Outcome Measures
NameTimeMethod
The mean difference of visual analog scale after deliveryimmediately

the scale is graded from 0 to 10

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Assiut Faculty of Medicine

🇪🇬

Assiut, Egypt

© Copyright 2025. All Rights Reserved by MedPath